|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of premium and accretion of discount on securities, net | |||||
| Amortization of restricted stock | |||||
| Amortization of intangible assets | |||||
| Amortization of subordinated debt costs | |||||
| Provision for credit losses | |||||
| Stock-based compensation and employee stock purchase plan expense | |||||
| Deferred tax expense/(benefit) | |||||
| Fair value adjustment for equity security | |||||
| Gain on sale of securities, available for sale, net | |||||
| Proceeds from sales of loans held for sale (A) | |||||
| Loans originated for sale (A) | |||||
| Gain on loans held for sale (A) | |||||
| Gain on OREO sold | |||||
| Loss/(gain) on loans held for sale at lower of cost or fair value | |||||
| Loss on disposal of fixed assets | |||||
| Gain on life insurance death benefit | |||||
| Increase in cash surrender value of life insurance, net | |||||
| (Increase)/decrease in accrued interest receivable | |||||
| Increase in other assets | |||||
| (Decrease)/increase in accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Principal repayments, maturities and calls of securities held to maturity | |||||
| Principal repayments, maturities and calls of securities available for sale | |||||
| Redemptions for FHLB & FRB stock | |||||
| Sales of securities available for sale | |||||
| Proceeds from sales of equity securities | |||||
| Purchase of securities held to maturity | |||||
| Purchase of securities available for sale | |||||
| Purchase of FHLB & FRB stock | |||||
| Proceeds from sale of loans held for sale at lower of cost or fair value | |||||
| Net increase in loans, net of participations sold | |||||
| Sales of OREO | |||||
| Purchases of premises and equipment | |||||
| Disposal of premises and equipment | |||||
| Proceeds from life insurance death benefit | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Net increase in deposits | |||||
| Net increase/(decrease) in short-term borrowings | |||||
| Dividends paid on common stock | |||||
| Exercise of stock options, net of stock swaps | |||||
| Restricted stock repurchased on vesting to pay taxes | |||||
| Issuance of restricted stock | |||||
| Redemption of subordinated debt | |||||
| Equity adjustment related to REIT minority interest | |||||
| Issuance of shares for employee stock purchase plan | |||||
| Shares repurchased | |||||
| Net cash provided by financing activities | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income tax, net | |||||
| Right-of-use asset obtained in exchange for operating lease liabilities | |||||
Loading...